Access 2.8M+ Filings Sign Up Free
Nordic Nanovector Logo

Nordic Nanovector | NANOV - Profile, Filings, Stock Info & Investor Relations Data

Nordic Nanovector | NANOV
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Biotechnology
Country
Norway
Founded
2009
Nordic Nanovector (NANOV)

Company Profile

Website
Investor Relations

About Nordic Nanovector

Nordic Nanovector is a leader in the development of CD37-targeted radionuclide therapies for haematological cancers.

Nordic Nanovector’s pipeline includes:
- Betalutin®, clinically safe and effective CD37-targeting radioimmunotherapy incorporating the beta emitter lutetium-177 and the murine antibody lilotomab for treatment of non-Hodgkin's lymphoma (NHL)
- Humalutin®, IND ready CD37-targeting radioimmunotherapy incorporating the beta emitter lutetium-177 and the chimeric antibody NNV003 for treatment of non-Hodgkin's lymphoma (NHL)
- 89Zr-NNV003, CD37-targeting companion PET diagnostic for detection and dosimetry of CD37 expressing tumors
- Alpha37, a CD37-targeting radioimmunotherapy candidate incorporating the alpha-particle generating radionuclide lead-212,

- Multiple fully humanized anti-CD37 antibodies with different effector mechanisms for treatment of haematological cancers and autoimmune diseases

- Undisclosed discovery projects in solid tumor indications

Market Presence

Worldwide

Headquarters

Kjelsåsveien 168B
0884, Oslo
Norway

Company Video

Video thumbnail
Click to load video from YouTube

Nordic Nanovector (NANOV)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

Nordic Nanovector (NANOV)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

No Insider Trades

There is currently no insider trading data available for this company.

Nordic Nanovector (NANOV)
Stock & Investor Information

ISINs

NO0010597883
NO0010815806

LEI

5967007LIEEXZXG6DK30

Stock Exchange Listings

Oslo Børs

Primary Stock Exchange Listing

View Nordic Nanovector on main exchange

Industry Classification

Sector
Health Care
Industry
Biotechnology